期刊文献+

抑癌基因蛋白PTEN,P16和P27在乳腺癌中表达及其临床病理意义 被引量:3

Expression and Clinicopathological Significance of PTEN,P16 and P27 in Breast Cancer
暂未订购
导出
摘要 目的研究抑癌基因蛋白PTEN,P16和P27在乳腺癌中的表达情况并探讨其临床病理意义。方法运用免疫组织化学染色S-P法,检测80例乳腺癌和30例乳腺纤维腺瘤组织中PTEN、P16和P27表达情况并分析其与淋巴结转移的关系。结果 80例乳腺癌组织的PTEN阳性表达率为53.75%(43/80),阴性表达率为46.25%(37/80);P16阳性表达率为36.25%(29/80),阴性表达率为63.75%(51/80);P27阳性表达率为45.00%(36/80),阴性表达率为55.00%(44/80)。三种抑癌基因蛋白的阳性表达率明显低于乳腺纤维腺瘤组织(P<0.01)。淋巴结未转移组PTEN阳性率45.00%(36/80),P16阳性率25.00%(20/80),P27阳性率35.00%(28/80)显著高于淋巴结转移组PTEN阳性率8.75%(7/80),P16阳性率11.25%(9/80),P27阳性率10.00%(8/80)(P<0.05)。结论乳腺癌组织中抑癌基因蛋白PTEN、P16和P27表达明显低于对照组且淋巴结未转移组的阳性率显著高于淋巴结转移组,PTEN、P16和P27为乳腺癌预后因子,可以作为判断乳腺癌预后的指标。 Objective To investigate the role of PTEN, P16 and P27 in the expression of breast cancer, and to explore the significance of clinic pathology. Methods The expressions of PTEN, P16 and P27 in 80 case of breast cancer and 30 case of mammary fiber adenoma were detected by means of immunocytochemistry, and the relationship with lymphatic metastasis was analyzed. Results The results showed that the positive expression rate of PTEN, P16 and P27 were 53.75% (43/80), 36.25% (29/80), 45.00% (36/80), as well as negative expression rate were 46.25% (37/80), 63.75% (51/80), 55.00% (44/80). Compared with the tissue of mammary fiber adenoma, the positive expression rate of breast cancer was significantly lower (P 〈0.01). The positive expression rate of non-lymphatic metastasis was significantly higher (P〈0.05). Conclusions The expression level of the all detected markers in breast cancer is significantly lower than the control group and the positive rate of non-lymphatic metastasis is significantly higher than lymphatic metastasis. As a result, PTEN, P16 and P27 are prognosis factors for breast cancer, which can be used as the indicators to estimate the prognosis of breast cancer.
出处 《临床医学工程》 2013年第3期283-284,共2页 Clinical Medicine & Engineering
基金 佛山市医学科学技术研究计划项目(项目编号:2011261)
关键词 PTEN P16 P27 乳腺癌 PTEN P16 P27 Breast carcinoma
  • 相关文献

参考文献9

  • 1Parkin DM,Bray F,Ferlay J,et al.Estimating the world cancer bur-den:Globocan2000[J].Int J Cancer,2001,94(2):153-156.
  • 2Li J,Yen C,Liaw D,et al.PTEN,a putative protein tyrosine phos phatase gene mutated in human brain,breast,and prostate cancer[J].Science,1997,275(5308):1943-1947.
  • 3Gimm O,Perren A,Weng LP,et al.Differential nuclear and cytoplas-mic expression of PTEN in normal thyroid tissue,and benign and ma-lignant epithelial thyroid tumors[J].Am J Pathol,2000,156(5):1693-1700.
  • 4Nohara T,Ryo T,Iwamoto S,et al.Expression of cell-cycle regulator p27is correlated to the prognosis and ER expression in breast carci noma patients[J].Oncology,2001,60(1):94-100.
  • 5Bose S,Crane A,Hibshoosh H,et al.Reduced expression of PTEN cor relates with breast cancer progression[J].Hum Pathol,2002,33(4):405-409.
  • 6Lee JS,Kim HS,Kim YB,et al.Reduced PTEN expression is associ ated with poor outcome and angiogenesis in invasive ductal carcinoma of the breast[J].Appl Immunohistochem Mol Morphol,2004,12(3):205-210.
  • 7郭洪斌,张培,王斌,王娟,刘意,白晓龙.p16蛋白、C-erbB-2在乳腺癌中表达的意义[J].中国老年学杂志,2005,25(6):718-719. 被引量:8
  • 8陈建武,王佩飞.乳腺癌相关基因蛋白的表达及意义[J].现代实用医学,2003,15(11):680-683. 被引量:3
  • 9Kouvaraki M,Gorgoulis VG,Rassidakis GZ,et al.High expression levels of p27correlate with lymph node status in a subset of advanced invasive breast carcinomas:relation to E-cadherin alterations,proliferative activi-ty,and ploidy of the tumors[J].Cancer,2002,94(9):2454-2465.

二级参考文献18

  • 1Jakes P, Rey MJ, Femandcs H, et al. Cyclin D1 and refnoblastoma gene expression in humun breast carcinoma: correlation with tumor proliferation and oestrogen receptor stalur[ J ]. J Pathol, 1997,128 : 160 - 166.
  • 2Caller C, Smith p, Cwegory W, et al. Cyclm D1 and prognosis in human breast cancer[ J]. Int J Cancer, 1996, 69:92 -99.
  • 3Kamb A, Gruis NA, Weaver-Feldhsus J, et al, A cell cycle regulator potentially involved in genesis of many lurnor types[J]. Scicnce, 1994,264 (5157): 436-440,.
  • 4Marx I. New tucnor suppressor on may rival p53[J]. Science,1994,264( 5157 ) : 344 - 345.
  • 5Harris AL. Mutanl p53 The commonest genetic abnormality in human cancer[J]. J Pathol, 1990,162( 1 ) :5 -6.
  • 6Milikan R, Hulka B, Ilia A, et al. p53 mutation in benign brenst tissue[J]. J Clin Oncol, 1995,13 (9):2293 -300.
  • 7卫生部医政司.中国常见恶性肿瘤诊治规范(乳腺癌)[M].北京:北京医科大学与中国协和医科大学联合出版,1991.53-6.
  • 8Traris J. Closing in on melanoma susceptibility gene [J]. Science, 1992;258(5085):1080-1.
  • 9Lo KW, Cheung ST, Leng SF, et al . Hypermethylation of p16 gene in nasopharyngeal carcinoma [J]. Cancer Res,1996;(12): 2721-5.
  • 10Salmon DJ, Godolphin W, Jones LA, et al . Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer [J]. Science, 1989;224(4905): 707-2.

共引文献8

同被引文献52

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部